Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Ballard
Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights Into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Related publications
Multitarget-Directed Drug Design Strategy: A Novel Molecule Designed to Block Epidermal Growth Factor Receptor (EGFR) and to Exert Proapoptotic Effects
Triazole Ureas Covalently Bind to Strigolactone Receptor and Antagonize Strigolactone Responses
Molecular Plant
Plant Science
Molecular Biology
Symmetrical Drug-Related Intertriginous and Flexural Exanthema Secondary to Epidermal Growth Factor Receptor Inhibitor Gefitinib
JAAD Case Reports
Dermatology
P185c-Neu and Epidermal Growth Factor Receptor Associate Into a Structure Composed of Activated Kinases.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A New Analysis Approach of Epidermal Growth Factor Receptor Pathway Activation Patterns Provides Insights Into Cetuximab Resistance Mechanisms in Head and Neck Cancer
BMC Medicine
Medicine
CrkII Signals From Epidermal Growth Factor Receptor to Ras.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Moving Osimertinib to First-Line: The Right “Strategy” in the Chessboard of Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer?
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Specific Drug Delivery to Cancer Cells With Double-Imprinted Nanoparticles Against Epidermal Growth Factor Receptor
Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
